share_log

Integra Lifesciences Analyst Ratings

Integra Lifesciences Analyst Ratings

Integra 生命科學分析師評級
Benzinga ·  2023/10/26 08:24
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/26/2023 4.68% Morgan Stanley $44 → $37 Maintains Underweight
08/24/2023 24.49% Morgan Stanley → $44 Downgrades Equal-Weight → Underweight
07/28/2023 69.76% JMP Securities $65 → $60 Maintains Outperform
07/19/2023 35.8% Truist Securities $44 → $48 Maintains Hold
07/12/2023 49.95% Jefferies $58 → $53 Upgrades Hold → Buy
06/08/2023 — Argus Research Downgrades Buy → Hold
05/31/2023 21.66% Morgan Stanley $59 → $43 Maintains Equal-Weight
05/30/2023 24.49% Truist Securities $54 → $44 Reiterates Hold → Hold
05/26/2023 83.9% JMP Securities → $65 Reiterates Market Outperform → Market Outperform
05/24/2023 21.66% JP Morgan $56 → $43 Downgrades Neutral → Underweight
05/23/2023 10.34% Citigroup $59 → $39 Downgrades Neutral → Sell
05/18/2023 52.78% Truist Securities $58 → $54 Maintains Hold
04/27/2023 83.9% JMP Securities $75 → $65 Maintains Outperform
04/17/2023 75.41% Truist Securities $58 → $62 Maintains Hold
02/23/2023 66.93% Citigroup $60 → $59 Maintains Neutral
01/06/2023 66.93% Morgan Stanley $50 → $59 Maintains Equal-Weight
12/20/2022 64.1% Truist Securities $52 → $58 Maintains Hold
12/12/2022 69.76% Citigroup $50 → $60 Maintains Neutral
10/27/2022 112.19% JMP Securities $85 → $75 Maintains Market Outperform
10/27/2022 41.46% Morgan Stanley $49 → $50 Maintains Equal-Weight
10/26/2022 47.12% Truist Securities $46 → $52 Maintains Hold
10/17/2022 30.15% Truist Securities $60 → $46 Maintains Hold
10/12/2022 35.8% Jefferies → $48 Initiates Coverage On → Hold
10/11/2022 38.63% Morgan Stanley $58 → $49 Maintains Equal-Weight
08/25/2022 64.1% Morgan Stanley $59 → $58 Maintains Equal-Weight
07/25/2022 66.93% Morgan Stanley → $59 Initiates Coverage On → Equal-Weight
07/20/2022 58.44% Truist Securities $70 → $56 Maintains Hold
05/17/2022 89.56% Citigroup $70 → $67 Maintains Neutral
01/18/2022 83.9% B of A Securities $55 → $65 Maintains Underperform
12/17/2021 112.19% JP Morgan → $75 Upgrades Underweight → Neutral
11/03/2021 146.15% Credit Suisse $84 → $87 Maintains Outperform
09/15/2021 — BTIG Downgrades Buy → Neutral
02/19/2021 123.51% Credit Suisse $73 → $79 Maintains Outperform
01/27/2021 126.34% JMP Securities $65 → $80 Maintains Market Outperform
01/07/2021 106.54% Credit Suisse $60 → $73 Maintains Outperform
10/29/2020 32.97% Piper Sandler $53 → $47 Maintains Neutral
10/08/2020 41.46% JP Morgan → $50 Downgrades Neutral → Underweight
08/12/2020 69.76% Truist Securities $55 → $60 Maintains Buy
08/11/2020 49.95% UBS $51 → $53 Maintains Neutral
08/11/2020 69.76% Credit Suisse $58 → $60 Maintains Outperform
05/08/2020 55.61% UBS $65 → $55 Maintains Neutral
05/08/2020 64.1% Credit Suisse $56 → $58 Maintains Outperform
05/08/2020 83.9% JMP Securities $75 → $65 Maintains Market Outperform
04/06/2020 30.15% Wells Fargo $62 → $46 Maintains Equal-Weight
04/03/2020 55.61% SunTrust Robinson Humphrey → $55 Initiates Coverage On → Buy
03/06/2020 83.9% Credit Suisse $70 → $65 Maintains Outperform
02/20/2020 83.9% UBS $64 → $65 Maintains Neutral
01/07/2020 64.1% Piper Sandler $59 → $58 Downgrades Overweight → Neutral
12/18/2019 83.9% UBS $63 → $65 Maintains Neutral
10/08/2019 83.9% Wells Fargo $68 → $65 Maintains Market Perform
01/03/2019 58.44% SunTrust Robinson Humphrey → $56 Initiates Coverage On → Buy
12/18/2018 61.27% Credit Suisse → $57 Initiates Coverage On → Outperform
12/12/2018 61.27% Credit Suisse → $57 Initiates Coverage On → Outperform
11/28/2018 64.1% UBS → $58 Initiates Coverage On → Neutral
11/02/2018 69.76% Citigroup $66 → $60 Maintains Neutral
11/02/2018 75.41% JMP Securities $66 → $62 Maintains Market Outperform
11/01/2018 55.61% Wells Fargo $61 → $55 Maintains Market Perform
11/01/2018 52.78% Cantor Fitzgerald $59 → $54 Maintains Neutral
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
2023年10月26日 4.68% 摩根士丹利 $44→$37 維護 體重不足
2023年08月24日 24.49% 摩根士丹利 →$44 評級下調 等重→減碼
07/28/2023 69.76% JMP證券 $65→$60 維護 跑贏大盤
07/19/2023 35.8% Truist證券 $44→$48 維護 保持
07/12/2023 49.95% 傑富瑞 $58→$53 升級 持有→購買
06/08/2023 - Argus研究 評級下調 購買→Hold
2023年05月31日 21.66% 摩根士丹利 $59→$43 維護 等重
2023年05月30日 24.49% Truist證券 $54→$44 重申 保持→保持
2023年05月26日 83.9% JMP證券 →$65 重申 市場表現優於→市場表現
2023年05月24日 21.66% 摩根大通 $56→$43 評級下調 中性→減持
2023年05月23日 10.34% 花旗集團 $59→$39 評級下調 中性→銷售
2023年05月18日 52.78% Truist證券 $58→$54 維護 保持
04/27/2023 83.9% JMP證券 $75→$65 維護 跑贏大盤
04/17/2023 75.41% Truist證券 $58→$62 維護 保持
02/23/2023 66.93% 花旗集團 $60→$59 維護 中性
01/06/2023 66.93% 摩根士丹利 $50→$59 維護 等重
12/20/2022 64.1% Truist證券 $52→$58 維護 保持
2022年12月12日 69.76% 花旗集團 $50→$60 維護 中性
10/27/2022 112.19% JMP證券 $85→$75 維護 市場表現強於大盤
10/27/2022 41.46% 摩根士丹利 $49→$50 維護 等重
10/26/2022 47.12% Truist證券 $46→$52 維護 保持
10/17/2022 30.15% Truist證券 $60→$46 維護 保持
10/12/2022 35.8% 傑富瑞 →$48 開始承保 →保留
2022年10月11日 38.63% 摩根士丹利 $58→$49 維護 等重
2022年08月25日 64.1% 摩根士丹利 $59→$58 維護 等重
07/25/2022 66.93% 摩根士丹利 →$59 開始承保 →等重
07/20/2022 58.44% Truist證券 $70→$56 維護 保持
2022/05/17 89.56% 花旗集團 $70→$67 維護 中性
01/18/2022 83.9% B of A證券 $55→$65 維護 表現不佳
2021/12/17 112.19% 摩根大通 →$75 升級 減重→中性
11/03/2021 146.15% 瑞士信貸 $84→$87 維護 跑贏大盤
2021/09/15 - BTIG 評級下調 購買→中性
02/19/2021 123.51% 瑞士信貸 $73→$79 維護 跑贏大盤
2021/01/27 126.34% JMP證券 $65→$80 維護 市場表現強於大盤
01/07/2021 106.54% 瑞士信貸 $60→$73 維護 跑贏大盤
10/29/2020 32.97% 派珀·桑德勒 $53→$47 維護 中性
10/08/2020 41.46% 摩根大通 →$50 評級下調 中性→減持
2020年08月12日 69.76% Truist證券 $55→$60 維護 買
2020年08月11日 49.95% 瑞銀集團 $51→$53 維護 中性
2020年08月11日 69.76% 瑞士信貸 $58→$60 維護 跑贏大盤
05/08/2020 55.61% 瑞銀集團 $65→$55 維護 中性
05/08/2020 64.1% 瑞士信貸 $56→$58 維護 跑贏大盤
05/08/2020 83.9% JMP證券 $75→$65 維護 市場表現強於大盤
04/06/2020 30.15% 富國銀行 $62→$46 維護 等重
04/03/2020 55.61% SunTrust Robinson Humphrey →$55 開始承保 →購買
03/06/2020 83.9% 瑞士信貸 $70→$65 維護 跑贏大盤
02/20/2020 83.9% 瑞銀集團 $64→$65 維護 中性
1/07/2020 64.1% 派珀·桑德勒 $59→$58 評級下調 超重→中性
2019年12月18日 83.9% 瑞銀集團 $63→$65 維護 中性
2019年10月08日 83.9% 富國銀行 $68→$65 維護 市場表現
2019年03月01日 58.44% SunTrust Robinson Humphrey →$56 開始承保 →購買
2018年12月18日 61.27% 瑞士信貸 →$57 開始承保 →跑贏大盤
2018年12月12日 61.27% 瑞士信貸 →$57 開始承保 →跑贏大盤
2018年11月28日 64.1% 瑞銀集團 →$58 開始承保 →中性
11/02/2018 69.76% 花旗集團 $66→$60 維護 中性
11/02/2018 75.41% JMP證券 $66→$62 維護 市場表現強於大盤
2018/11/01 55.61% 富國銀行 $61→$55 維護 市場表現
2018/11/01 52.78% 康託·菲茨傑拉德 $59→$54 維護 中性

What is the target price for Integra Lifesciences (IART)?

Integra Lifesciences(IART)的目標價格是多少？

The latest price target for Integra Lifesciences (NASDAQ: IART) was reported by Morgan Stanley on October 26, 2023. The analyst firm set a price target for $37.00 expecting IART to rise to within 12 months (a possible 4.68% upside). 20 analyst firms have reported ratings in the last year.

納斯達克(Tmall：IART)2023年10月26日報道了INCELA LIFESSIONS的最新目標價。這家分析公司將目標價定為37.00美元，預計iart將在12個月內上漲(可能上漲4.68%)。去年，已有20家分析公司公佈了評級。

What is the most recent analyst rating for Integra Lifesciences (IART)?

Integra生命科學(IART)的最新分析師評級是多少？

The latest analyst rating for Integra Lifesciences (NASDAQ: IART) was provided by Morgan Stanley, and Integra Lifesciences maintained their underweight rating.

納斯達克(Sequoia Capital：IART)分析師對該公司的最新評級由摩根士丹利提供，該公司維持其減持評級。

When is the next analyst rating going to be posted or updated for Integra Lifesciences (IART)?

Integra Lifesciences(IART)的下一次分析師評級將於何時發佈或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Integra Lifesciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Integra Lifesciences was filed on October 26, 2023 so you should expect the next rating to be made available sometime around October 26, 2024.

分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Integra Lifesciences的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Integra生命科學的最後一次評級是在2023年10月26日提交的，所以你應該預計下一次評級將在2024年10月26日左右的某個時候提供。

Is the Analyst Rating Integra Lifesciences (IART) correct?

分析師對Integra Lifesciences(IART)的評級正確嗎？

While ratings are subjective and will change, the latest Integra Lifesciences (IART) rating was a maintained with a price target of $44.00 to $37.00. The current price Integra Lifesciences (IART) is trading at is $35.35, which is out of the analyst's predicted range.

雖然評級是主觀的，並將發生變化，但最新的Integra Lifesciences(IART)評級保持不變，目標價在44.00美元至37.00美元之間。Integra Lifesciences(IART)目前的交易價格為35.35美元，超出了分析師的預測區間。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論